Keith R. Walley

Active 1984–2025

105
Papers
18,308
Citations
76
h-index
103
i10-index

Citations

Citations per year for Keith R. Walley1985: 1 citations1986: 1 citations1988: 2 citations1989: 1 citations1990: 1 citations1992: 3 citations1993: 8 citations1994: 12 citations1995: 6 citations1996: 15 citations1997: 10 citations1998: 25 citations1999: 21 citations2000: 27 citations2001: 23 citations2002: 22 citations2003: 81 citations2004: 67 citations2005: 56 citations2006: 59 citations2007: 38 citations2008: 79 citations2009: 95 citations2010: 96 citations2011: 65 citations2012: 97 citations2013: 126 citations2014: 128 citations2015: 113 citations2016: 139 citations2017: 150 citations2018: 132 citations2019: 471 citations2020: 540 citations2021: 464 citations2022: 377 citations2023: 350 citations2024: 544 citations2025: 259 citations2026: 17 citations1987: no citations, so this year is not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,563 citing papers, 23.2% of this breakdownChina: 570 citing papers, 8.4% of this breakdownUnited Kingdom: 487 citing papers, 7.2% of this breakdownCanada: 456 citing papers, 6.7% of this breakdownGermany: 301 citing papers, 4.5% of this breakdownFrance: 301 citing papers, 4.5% of this breakdownItaly: 262 citing papers, 3.9% of this breakdownNetherlands: 250 citing papers, 3.7% of this breakdownAustralia: 236 citing papers, 3.5% of this breakdownSpain: 170 citing papers, 2.5% of this breakdownBelgium: 169 citing papers, 2.5% of this breakdownBrazil: 139 citing papers, 2.1% of this breakdown
0%23.2%Other 27.3%

Fields

  • Medicine76.3%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Immunology and Microbiology6.7%
  • Engineering1.7%
  • Nursing1.1%
  • Neuroscience0.8%
  • Other3.2%

Topics

  • Sepsis Diagnosis and Treatment12.7%
  • Hemodynamic Monitoring and Therapy5.2%
  • Immune Response and Inflammation4.2%
  • Trauma, Hemostasis, Coagulopathy, Resuscitation3.2%
  • Acute Kidney Injury Research3%
  • Respiratory Support and Mechanisms2.6%
  • Other69.1%

Coauthors

All papers

Open in search
  1. Redefining critical illness

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce Thompson, Tom van der Poll, Balasubramanian Venkatesh, Keith R. Walley, Timothy Walsh, Lorraine B. Ware, Hector R. Wong, Zsolt Zádor, John C. Marshall - Nature Medicine 2022 cited by 363

  2. Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,882

  3. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2023 cited by 194

  4. Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality*

    Authors: , , , , - Critical Care Medicine 2010 cited by 1,534

  5. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , - EClinicalMedicine 2020 cited by 276

  6. Lactic Acidosis in Sepsis: It’s Not All Anaerobic

    Authors: , - CHEST Journal 2015 cited by 406

  7. Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 cited by 211

  8. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2010 cited by 589

  9. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials

    Authors: , , , , , , , , - Intensive Care Medicine 2019 cited by 160

  10. PCSK9 is a critical regulator of the innate immune response and septic shock outcome

    Authors: , , , , , , , , , , , - Science Translational Medicine 2014 cited by 370

  11. S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products

    Authors: , , , , - Circulation Research 2008 cited by 303

  12. Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis

    Authors: , , , , , - Journal of Critical Care 2016 cited by 183

  13. Sepsis-induced myocardial dysfunction

    Authors: - Current Opinion in Critical Care 2018 cited by 168

  14. Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis

    Authors: , , , , , , , , , , , , , , , - Circulation 2020 cited by 110

  15. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-κB dependent inflammatory response☆

    Authors: , , , , - Cardiovascular Research 2006 cited by 372

  16. Clinical review: Update on hemodynamic monitoring - a consensus of 16

    Authors: , , , , , , , , , , , , , , , - Critical Care 2011 cited by 415

  17. Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease

    Authors: , , , - Arteriosclerosis Thrombosis and Vascular Biology 2019 cited by 146

  18. Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elaine Gilfoyle, Jamie Hutchison, Lili‐Naz Hazrati, Robin Green, Shannon E. Scratch, Elisa Wilson, Arash Khosroawshahi, Catherine Farrell, Jacques Lacroix - Critical Care 2023 cited by 37

  19. Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Holloway, Julian C. Knight, Chris Garrard, James A. Russell, Keith R. Walley, Frank Stüber, Adrian V. S. Hill, Charles Hinds - The Lancet Respiratory Medicine 2014 cited by 198

  20. Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis

    Authors: , , , , , - Journal of Innate Immunity 2016 cited by 158

  21. Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jing Li, Kenneth Lim, Sarka Lisonkova, Paula Lott, Jennifer M. Menzies, Alexandra Millman, Lynne Palmer, Beth A. Payne, Ziguang Qu, James A. Russell, Diane Sawchuck, Dorothy Shaw, Douglas K. Still, Ugochinyere Vivian Ukah, Brenda Wagner, Keith R. Walley, Dany Hugo, The late Andrée Gruslin, George Tawagi, Graeme N. Smith, Anne‐Marie Côté, Jean‐Marie Moutquin, Annie Ouellet, Shoo K. Lee, Tao Duan, Jian Zhou, The late Farizah Haniff, Swati Mahajan, Amanda Noovao, Hanna Karjalainend, Alja Kortelainen, Hannele Laivuori, J. Wessel Ganzevoort, Henk Groen, Phillipa M. Kyle, M. Peter Moore, Barbra Pullar, Zulfiqar A Bhutta, Rahat Qureshi, Rozina Sikandar, The late Shereen Z. Bhutta, Garth Cloete, David Hall, The late Erika van Papendorp, D.W. Steyn, Christine Biryabarema, Florence Mirembe, Annettee Nakimuli, John Allotey, Shakila Thangaratinam, K. H. Nicolaides, Olivia Ionescu, Argyro Syngelaki, Michael de Swiet, Laura A. Magee, Peter von Dadelszen, Ranjit Akolekar, James J. Walker, Stephen C. Robson, Fiona Broughton-Pipkin, Pamela Loughna, Manu Vatish, Christopher W.G. Redman, Sarah Barry, Kimberley Kavanagh, Tunde Montgomery-Csobán, Paul Murray, Chris Robertson, Eleni Tsigas, Douglas Woelkers and 5 more - The Lancet Digital Health 2024 cited by 42

  22. Physiology of Vasopressin Relevant to Management of Septic Shock

    Authors: , , , - CHEST Journal 2001 cited by 620

  23. Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

    Authors: , , , , , , , , , , , , , , - eLife 2016 cited by 151

  24. Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor

    Authors: , , , , , , - PLoS ONE 2016 cited by 143